We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.82B
AUM Growth
+$646M
Cap. Flow
+$669M
Cap. Flow %
36.8%
Top 10 Hldgs %
93.31%
Holding
25
New
6
Increased
6
Reduced
6
Closed
1

Top Sells

Rank Stock Value
1
UBER icon
Uber
UBER
+$12.9M
2
NCNA
NuCana
NCNA
+$3.09M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.41M
4
GLD icon
SPDR Gold Trust
GLD
+$2.4M
5
BNTX icon
BioNTech
BNTX
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 39.79%
2 Communication Services 28.28%
3 Technology 15.35%
4 Financials 6.39%
5 Consumer Discretionary 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$26.1B
$618M 33.99%
14,690,780
META icon
2
Meta Platforms (Facebook)
META
$1.51T
$285M 15.66%
1,087,633
+917,850
+541% +$237M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.91T
$229M 12.62%
3,130,860
+1,867,900
+148% +$142M
PANW icon
4
Palo Alto Networks
PANW
$264B
$178M 9.77%
4,357,326
+2,301,654
+112% +$95.7M
ICE icon
5
Intercontinental Exchange
ICE
$82.4B
$116M 6.39%
+1,161,137
New +$114M
UBER icon
6
Uber
UBER
$134B
$99.3M 5.46%
2,720,937
-391,249
-13% -$12.9M
LNW
7
DELISTED
Light & Wonder
LNW
$93.5M 5.14%
+2,678,571
New +$57.4M
QQQ icon
8
Invesco QQQ Trust
QQQ
$455B
$31.5M 1.73%
113,262
+47,589
+72% +$12.9M
RVMD icon
9
Revolution Medicines
RVMD
$40.2B
$23.3M 1.28%
670,382
RLAY icon
10
Relay Therapeutics
RLAY
$4.02B
$23M 1.27%
+541,124
New +$20.6M
IVV icon
11
iShares Core S&P 500 ETF
IVV
$876B
$21.7M 1.2%
64,672
+909
+1% +$303K
GLD icon
12
SPDR Gold Trust
GLD
$131B
$21.1M 1.16%
119,014
-13,358
-10% -$2.4M
GBIO
13
DELISTED
Generation Bio
GBIO
$15.6M 0.86%
50,627
PLRX icon
14
Pliant Therapeutics
PLRX
$67.5M
$12.7M 0.7%
562,379
NCNA
15
NuCana
NCNA
$5.37M
$12.1M 0.66%
464
-114
-20% -$3.09M
NRIX icon
16
Nurix Therapeutics
NRIX
$2.43B
$11M 0.6%
+314,762
New +$7.93M
VEA icon
17
Vanguard FTSE Developed Markets ETF
VEA
$226B
$7.12M 0.39%
174,041
-58,697
-25% -$2.41M
IJR icon
18
iShares Core S&P Small-Cap ETF
IJR
$109B
$3.49M 0.19%
49,710
-3,288
-6% -$236K
VWO icon
19
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$3.48M 0.19%
80,360
+2,161
+3% +$93.9K
IJH icon
20
iShares Core S&P Mid-Cap ETF
IJH
$123B
$3.44M 0.19%
92,720
-18,610
-17% -$696K
FULC icon
21
Fulcrum Therapeutics
FULC
$248M
$3.26M 0.18%
410,714
DNTH icon
22
Dianthus Therapeutics
DNTH
$5.68B
$2.26M 0.12%
20,788
ASAN icon
23
Asana
ASAN
$1.58B
$2.19M 0.12%
+75,946
New +$2.19M
DYN icon
24
Dyne Therapeutics
DYN
$4.04B
$2.17M 0.12%
+107,252
New +$2.35M
BNTX icon
25
BioNTech
BNTX
$22.6B
-31,869
Closed -$2.13M

Similar funds

Harvard Management Company's Q3 2020 Portfolio in Review

As of Q3 2020, Harvard Management Company held 25 positions worth $1.82B, up 55% from $1.17B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Harvard Management Company deployed $669M of net new capital in Q3 2020, opening 6 new positions and adding to 6 existing holdings. Its largest new stake was Intercontinental Exchange: 1,161,137 shares worth $116M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 67% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Uber, an estimated $12.9M trimmed.

  • Harvard Management Company's largest Q3 2020 buy was Intercontinental Exchange: 1,161,137 shares worth $116M.
  • Harvard Management Company added most to Meta Platforms (Facebook) in Q3 2020, an estimated $237M increase.
  • Harvard Management Company's biggest Q3 2020 reduction was Uber, cutting an estimated $12.9M.
  • Harvard Management Company fully exited BioNTech in Q3 2020, selling an estimated $2.13M.
  • Harvard Management Company's ten largest holdings make up 93% of its $1.82B portfolio in Q3 2020.
  • Harvard Management Company opened 6 new positions and closed 1 in Q3 2020.
  • Harvard Management Company's portfolio value rose 55% quarter-over-quarter to $1.82B.

Based on Harvard Management Company's 13F filing for Q3 2020, filed 13 Nov 2020.